Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In Sil Choi

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Journal of Breast Cancer|December 30, 2017
Treatment Patterns and Outcomes in Elderly Patients with Metastatic Breast Cancer: A Multicenter Retrospective StudyJin Hyun Park, In Sil Choi, Ki Hwan Kim, et al.
The Korean Journal of Internal Medicine|February 23, 2018
Costs and clinical outcomes of patients with diffuse large B-cell lymphoma in first remission: role of PET/CT surveillanceKoung Jin Suh, Ki Hwan Kim, Ryul Kim, et al.
Breast Cancer (Tokyo, Japan)|May 26, 2022
Racial differences in predictive value of the 21-gene recurrence score assay: a population-based study using the SEER databaseJiwoong Jung, Ki-Tae Hwang, In Sil Choi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2021
A randomised phase II study of oxaliplatin/5-FU (mFOLFOX) versus irinotecan/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to first-line gemcitabine/cisplatin chemotherapyIn Sil Choi, Ki Hwan Kim, Ju Hyun Lee, et al.
Medicine|September 9, 2025
Case report of extranodal NK/T-cell lymphoma mimicking Behcet syndromeSongyi Park, Jeemin Yim, Hye Eun Park, et al.
Annals of Hematology|April 28, 2022
Characteristics of Sweet syndrome in patients with or without malignancyEun Hee Jung, Jin Hyun Park, Ki Hwan Kim, et al.
Cancer Chemotherapy and Pharmacology|July 7, 2009
A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancerDo-Youn Oh, Yongjun Cha, In-Sil Choi, et al.
Journal of Surgical Oncology|November 11, 2022
Prognostic roles of leptin-signaling proteins, PD-L1, and tumor-infiltrating lymphocytes in surgically-resected biliary tract cancersSun-Ju Byeon, Mee Soo Chang, Hwa Jin Cho, et al.
Cancer Chemotherapy and Pharmacology|August 25, 2010
Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysisJunshik Hong, Sae-Won Han, Hye Seon Ham, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2002
Efficacy of modified regimen with attenuated doses of paclitaxel plus carboplatin combination chemotherapy in elderly and/or weak patients with advanced non-small cell lung cancerIn Sil Choi, Byung Su Kim, Sook Ryun Park, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Journal of Breast Cancer|December 30, 2017
Treatment Patterns and Outcomes in Elderly Patients with Metastatic Breast Cancer: A Multicenter Retrospective StudyJin Hyun Park, In Sil Choi, Ki Hwan Kim, et al.
The Korean Journal of Internal Medicine|February 23, 2018
Costs and clinical outcomes of patients with diffuse large B-cell lymphoma in first remission: role of PET/CT surveillanceKoung Jin Suh, Ki Hwan Kim, Ryul Kim, et al.
Breast Cancer (Tokyo, Japan)|May 26, 2022
Racial differences in predictive value of the 21-gene recurrence score assay: a population-based study using the SEER databaseJiwoong Jung, Ki-Tae Hwang, In Sil Choi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2021
A randomised phase II study of oxaliplatin/5-FU (mFOLFOX) versus irinotecan/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to first-line gemcitabine/cisplatin chemotherapyIn Sil Choi, Ki Hwan Kim, Ju Hyun Lee, et al.
Medicine|September 9, 2025
Case report of extranodal NK/T-cell lymphoma mimicking Behcet syndromeSongyi Park, Jeemin Yim, Hye Eun Park, et al.
Annals of Hematology|April 28, 2022
Characteristics of Sweet syndrome in patients with or without malignancyEun Hee Jung, Jin Hyun Park, Ki Hwan Kim, et al.
Cancer Chemotherapy and Pharmacology|July 7, 2009
A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancerDo-Youn Oh, Yongjun Cha, In-Sil Choi, et al.
Journal of Surgical Oncology|November 11, 2022
Prognostic roles of leptin-signaling proteins, PD-L1, and tumor-infiltrating lymphocytes in surgically-resected biliary tract cancersSun-Ju Byeon, Mee Soo Chang, Hwa Jin Cho, et al.
Cancer Chemotherapy and Pharmacology|August 25, 2010
Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysisJunshik Hong, Sae-Won Han, Hye Seon Ham, et al.
Lung Cancer (Amsterdam, Netherlands)|December 25, 2002
Efficacy of modified regimen with attenuated doses of paclitaxel plus carboplatin combination chemotherapy in elderly and/or weak patients with advanced non-small cell lung cancerIn Sil Choi, Byung Su Kim, Sook Ryun Park, et al.
Pageof 7